Search

Displaying results 9001 - 9010 of 10000 in total
  1. Drug

    Labetuzumab govitecan

    go.drugbank.com/drugs/DB12331
    Investigational

    Labetuzumab govitecan has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, and Metastatic Colorectal Cancer.

  2. Drug

    10-hydroxycamptothecin

    go.drugbank.com/drugs/DB12385
    Experimental

    10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)).

  3. Drug

    Tributyrin

    go.drugbank.com/drugs/DB12709
    Investigational

    Tributyrin has been used in trials studying the treatment of Prostate Cancer and Unspecified Adult Solid Tumor, Protocol Specific.

  4. Drug

    Indoximod

    go.drugbank.com/drugs/DB12827
    Investigational

    Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others.

  5. Drug

    Lerisetron

    go.drugbank.com/drugs/DB12964
    Investigational

    Lerisetron has been used in trials studying the supportive care of Nausea and Vomiting and Testicular Germ Cell Tumor.

  6. Drug

    X-376

    go.drugbank.com/drugs/DB13104
    Investigational

    X-376 is an inhibitor of the anaplastic lymphoma kinase (ALK) which can penetrate the blood brain barrier.[A265085]

  7. Drug

    CTS-1027

    go.drugbank.com/drugs/DB08490
    Investigational

    CTS-1027 has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection.

  8. Drug

    DADLE

    go.drugbank.com/drugs/DB08856
    Experimental

    It can cause transient depression of mean arterial blood pressure and heart rate.

  9. Drug

    Zorifertinib

    go.drugbank.com/drugs/DB14795
    Investigational

    AZD-3759 is under investigation in clinical trial NCT03360929 (Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759).

  10. Drug

    Uliledlimab

    go.drugbank.com/drugs/DB16675
    Investigational

    Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for Advanced Solid Tumor).